Canopy Growth Stock (NASDAQ:CGC)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.91

52W Range

$0.84 - $2.38

50D Avg

$0.99

200D Avg

$1.13

Market Cap

$375.13M

Avg Vol (3M)

$6.02M

Beta

2.42

Div Yield

-

CGC Company Profile


Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

1,128

IPO Date

Apr 07, 2014

Website

CGC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 26Mar 25Mar 24
Other Revenue--$10.19M
Canadian Cannabis Net Revenue-$155.86M-
International And Other Revenue-$39.73M-
Storz And Bickel-$73.40M-

Fiscal year ends in Mar 26 | Currency in USD

CGC Financial Summary


Mar 26Mar 25Mar 24
Revenue$346.83M$269.00M$297.15M
Operating Income$-161.66M$-117.14M$-228.71M
Net Income$-262.91M$-598.12M$-657.27M
EBITDA$-161.66M$-479.31M$-312.83M
Basic EPS$-0.88$-5.53$-6.47
Diluted EPS$-0.88$-5.53$-8.79

Fiscal year ends in Mar 26 | Currency in USD

Latest Earnings Call Transcripts


Q3 26Feb 06, 26 | 10:00 AM
Q2 26Nov 07, 25 | 10:00 AM
Q1 26Aug 08, 25 | 10:00 AM

Peer Comparison


TickerCompany
BIOABioAge Labs Inc.
ACBAurora Cannabis Inc.
OMIOwens & Minor, Inc.
IRWDIronwood Pharmaceuticals, Inc.
ACRSAclaris Therapeutics, Inc.
LFCRLifecore Biomedical, Inc.
LYELLyell Immunopharma, Inc.
CABACabaletta Bio, Inc.
DHDefinitive Healthcare Corp.
TKNOAlpha Teknova, Inc.